How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Identifying a Novel Variant of Klebsiella Pneumoniae

Examining COVID-19 Mortality Rates Against Specific Treatments for Inpatients

Contagion Winter 2024 Digital Edition

CDC Report and RECOVER Study Update

PCR Testing Linked to Better Outcomes in Complicated UTI than Culture/Sensitivity-Guided Treatment

Top 5 Infectious Disease News Stories Week of December 14-20

Gilead Submits FDA New Drug Application for Lenacapavir for HIV Prevention

The Slow-Moving Antimicrobial Resistance Train is Picking-up Morbidity and Mortality Steam

CACTUS Study Compares Ceftolozane-Tazobactam vs. Ceftazidime-Avibactam for MDR Pseudomonas

The First Severe Case of Avian Influenza Confirmed in the United States

Schedule an Appointment

Quick Links

Patient Forms

Contact Us